Stanley Aip Gp Lp Morgan serves as Executive at Sagent Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Stanley Aip Gp Lp Morgan has executed 12 insider transactions totaling $17.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2015 involved selling 61,883 shares valued at $1.6M.
Stanley Aip Gp Lp Morgan currently holds 3,225,093 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley Aip Gp Lp Morgan has been a net seller of SGNT stock. They have purchased $0 and sold $17.8M worth of shares.
Stanley Aip Gp Lp Morgan's most recent insider trade was on Jan 23, 2015, when they sold 61,883 shares at $25.90 per share.
Get notified when new Form 4 filings are submitted
| $25.49 |
| Discretionary |
| Jan 21, 2015 | SGNT | $1.1M | Sale | 44,316 | $25.22 | Discretionary |
| Jan 20, 2015 | SGNT | $631.0K | Sale | 25,000 | $25.24 | Discretionary |
| Jan 16, 2015 | SGNT | $1.3M | Sale | 50,000 | $25.26 | Discretionary |
| Jan 15, 2015 | SGNT | $1.9M | Sale | 75,000 | $25.10 | Discretionary |
| Jan 14, 2015 | SGNT | $1.3M | Sale | 50,000 | $25.53 | Discretionary |
| Jan 13, 2015 | SGNT | $1.3M | Sale | 50,000 | $25.49 | Discretionary |
| Oct 3, 2013 | SGNT | $969.4K | Sale | 47,826 | $20.27 | Discretionary |
| Sep 26, 2013 | SGNT | $1.4M | Sale | 67,965 | $20.37 | Discretionary |
| Sep 23, 2013 | SGNT | $596.4K | Sale | 27,843 | $21.42 | Discretionary |
| Sep 20, 2013 | SGNT | $2.0M | Sale | 91,714 | $21.96 | Discretionary |